Sanofi’s Zaltrap data published
October 8, 2012Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin
Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …
Chiltern announces new chief executive
October 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Jim Esinhart, chiltern
Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …
NICE does Lucentis U-turn
October 5, 2012Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin
NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …
Vernon named Digital Pioneer at PM Society awards
October 5, 2012Medical Communications Creative Lynx, GSK, PM Society Digital Awards, digital
A range of innovative digital programmes created by UK pharma companies and agencies were recognised at last night’s PM Society …
NHS under fire for ‘misdiagnosis’
October 5, 2012Sales and Marketing BHIVA, HIV, NHS
Patients with HIV infections are going unnoticed by the NHS while those with rare diseases are often being misdiagnosed. These …
Appointments and moves at the BIA
October 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association
The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …
Louise Tamblin rejoins Kantar Health
October 4, 2012Kantar Health, Louise Tamblin
Healthcare-focused consultancy and marketing firm Kantar Health has named Louise Tamblin as group director. Most recently Tamblin was head of …
NHS patient care ‘will worsen’
October 4, 2012Sales and Marketing A&E, MRSA, NHS, king's fund
Patient care will worsen over the next few years and the NHS will not meet its £20 billion productivity target …
Sanofi acquires leading Colombian firm
October 4, 2012Sales and Marketing Columbia, Genfar, Latin America, Sanofi
Sanofi is expanding its presence in Latin American with the acquisition of a Colombian pharma company. Genfar is headquartered in …
GW Pharmaceuticals hires chief operating officer
October 4, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals
GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …
Seebri Breezhaler approved in Europe
October 4, 2012Sales and Marketing COPD, Novartis, Relvar, Seebri Breezhaler, Tudorza
Novartis has been given approval in Europe for its Seebri Breezhaler to be used as maintenance treatment for chronic obstructive …
Patent losses force change for Sanofi
October 3, 2012Sales and Marketing Avapro, BMS, Plavix, Sanofi, patent loss
Patent expiries are behind the decision by Sanofi and Bristol-Myers Squibb to radically restructure their long-term corporate alliance. The loss …
Non-executive directors of NHS Trust appointed
October 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness
Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority. Ms Beasley (pictured) …
Quality issues prompt Sanofi typhoid vaccine recall
October 3, 2012Manufacturing and Production Sanofi, Typhen Vi, recall
Sanofi has recalled several lots of its typhoid fever vaccine Typhim Vi on fears that a quality defect could compromise …
Bayer signs endometriosis pact
October 3, 2012Research and Development, Sales and Marketing Bayer, Evotec, endometriosis
Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
Is it really safety first?
October 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche
The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …
Catalent and CTC Partner to Help Korean Pharma Take Their Products to Western Markets
October 2, 2012Research and Development
Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …
Catalent Enters Into Commerical Supply Agreement with Vivus for Qsymia™ Once-Daily Combination Extended-Release Capsules
October 2, 2012Manufacturing and Production
Somerset, NJ, October 1, 2012 – Catalent Pharma Solutions announced that it has entered into a Supply Agreement with VIVUS, …
Survival boost for Votrient in mRCC
October 2, 2012Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient
GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …
Government launches Healthwatch England
October 2, 2012Sales and Marketing HealthWatch, NHS, government
The government has launched Healthwatch England, a new statutory body whose role is to ensure the public’s voice is heard …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
